France · 
Who invested in MaaT Pharma?
MaaT Pharma's investors include Bpifrance, European Investment Bank, Seventure Partners and Invus.
France · Funded startup
Who invested in MaaT Pharma
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $11MNov 2025
- Investors
- 4
The rounds
- Nov 2025
Founders and team
From MaaT Pharma's own website: 1 founder, 10 on the team.
Jean-Marie LefevreCEO and co-founder
- Dorothée BurkelChief Corporate and People Operations Officer
- Emilie PlantamuraDeputy Chief Medical Officer
- Frédéric FasanoChief Strategy & Corporate Development Officer
- Sheri SimmonsActing Chief Scientific Officer
- Dr. Claude BertrandIndependent director
- Hervé AffagardIndependent director
- Isabelle de CrémouxNon-Executive Director
- Jean VolatierNon-Executive Director
- Muriel PrudentIndependent director
- Nadia KamalNon-Executive Director
AdvisersDr. Ernst HollerDr. Joël DoréPr. Mohamad Mohty
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about MaaT Pharma
How much has MaaT Pharma raised?
MaaT Pharma has raised $11M across 1 round since 2025.
When did MaaT Pharma last raise?
MaaT Pharma's most recent round was an Undisclosed round of $11M in Nov 2025.
What was MaaT Pharma's biggest round?
Its most recent round, $11M in Nov 2025, is also its largest on record.
Who backed MaaT Pharma first?
MaaT Pharma's first round on record, in Nov 2025, was backed by Bpifrance, European Investment Bank and Seventure Partners and 1 others.
What stage is MaaT Pharma at?
MaaT Pharma's latest named round is an Undisclosed round, in Nov 2025.
Where is MaaT Pharma based?
MaaT Pharma is based in France.
Companies like MaaT Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.